| Augusta Psychiatric Solutions | |
|
20902 Bright Lake Bend Ct Richmond TX 77407-4491 | |
| (832) 577-3808 | |
| Not Available |
| Full Name | Augusta Psychiatric Solutions |
|---|---|
| Speciality | Community/Behavioral Health |
| Location | 20902 Bright Lake Bend Ct, Richmond, Texas |
| Authorized Official Name and Position | Augusta Chika Anyama (MANAGER) |
| Authorized Official Contact | 8327578758 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Augusta Psychiatric Solutions 20902 Bright Lake Bend Ct Richmond TX 77407-4491 Ph: (832) 577-3808 | Augusta Psychiatric Solutions 20902 Bright Lake Bend Ct Richmond TX 77407-4491 Ph: (832) 577-3808 |
| NPI Number | 1164165288 |
|---|---|
| Provider Enumeration Date | 04/16/2022 |
| Last Update Date | 04/16/2022 |
| Certification Date | 04/16/2022 |
| Medicare PECOS PAC ID | 0840660288 |
|---|---|
| Medicare Enrollment ID | O20221230000255 |
News Archive
Phase II trials of the first second-generation antisense cancer drug to be used in patients are soon to be underway in the wake of a successful Phase I study, which has demonstrated that the new drug blocks its target gene in exactly the way it is designed to do.
The largest prospective trial ever examining the anti-inflammatory drug Vioxx as a chemoprevention agent found that the risk of developing a cardiovascular "event" - heart attacks and/or strokes - was almost double in patients who received the drug, compared to patients who took the placebo, according to a study out Feb. 15 on-line in The New England Journal of Medicine.
The IOF Medal of Achievement has been presented today to Professor Adolfo Diez-Perez, MD, PhD, Head Emeritus of the Department of Internal Medicine, Hospital del Mar, Director of the Bone and Joint Research Unit at the Municipal Institute of Medical Research and Professor of Medicine at the Autonomous University of Barcelona.
Another presentation at the International Stroke Conference today shows that prolonged periods of Holter-ECG monitoring markedly increase detection of paroxysmal atrial fibrillation in patients with stroke.
Scientists from Brigham and Women's Hospital and Dana-Farber Cancer Institute and their colleagues have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers will likely respond to platinum-based chemotherapies.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164165288 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 251S00000X | Community/behavioral Health | (* (Not Available)) | Primary |
| Provider Name | Augusta Chika Anyama |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1972126001 PECOS PAC ID: 7810906765 Enrollment ID: I20220111000802 |
News Archive
Phase II trials of the first second-generation antisense cancer drug to be used in patients are soon to be underway in the wake of a successful Phase I study, which has demonstrated that the new drug blocks its target gene in exactly the way it is designed to do.
The largest prospective trial ever examining the anti-inflammatory drug Vioxx as a chemoprevention agent found that the risk of developing a cardiovascular "event" - heart attacks and/or strokes - was almost double in patients who received the drug, compared to patients who took the placebo, according to a study out Feb. 15 on-line in The New England Journal of Medicine.
The IOF Medal of Achievement has been presented today to Professor Adolfo Diez-Perez, MD, PhD, Head Emeritus of the Department of Internal Medicine, Hospital del Mar, Director of the Bone and Joint Research Unit at the Municipal Institute of Medical Research and Professor of Medicine at the Autonomous University of Barcelona.
Another presentation at the International Stroke Conference today shows that prolonged periods of Holter-ECG monitoring markedly increase detection of paroxysmal atrial fibrillation in patients with stroke.
Scientists from Brigham and Women's Hospital and Dana-Farber Cancer Institute and their colleagues have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers will likely respond to platinum-based chemotherapies.
› Verified 7 days ago
News Archive
Phase II trials of the first second-generation antisense cancer drug to be used in patients are soon to be underway in the wake of a successful Phase I study, which has demonstrated that the new drug blocks its target gene in exactly the way it is designed to do.
The largest prospective trial ever examining the anti-inflammatory drug Vioxx as a chemoprevention agent found that the risk of developing a cardiovascular "event" - heart attacks and/or strokes - was almost double in patients who received the drug, compared to patients who took the placebo, according to a study out Feb. 15 on-line in The New England Journal of Medicine.
The IOF Medal of Achievement has been presented today to Professor Adolfo Diez-Perez, MD, PhD, Head Emeritus of the Department of Internal Medicine, Hospital del Mar, Director of the Bone and Joint Research Unit at the Municipal Institute of Medical Research and Professor of Medicine at the Autonomous University of Barcelona.
Another presentation at the International Stroke Conference today shows that prolonged periods of Holter-ECG monitoring markedly increase detection of paroxysmal atrial fibrillation in patients with stroke.
Scientists from Brigham and Women's Hospital and Dana-Farber Cancer Institute and their colleagues have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers will likely respond to platinum-based chemotherapies.
› Verified 7 days ago
Lisa S Whipple Counseling Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 2116 Thompson Rd Ste 102, Richmond, TX 77469 Phone: 281-250-6650 | |
Eric Consulting Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 7314 Ramsgate Cliff Ln, Richmond, TX 77407 Phone: 713-240-5722 | |
Anac. P.c. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5545 Fm 359 Rd Ste 17, Richmond, TX 77406 Phone: 281-265-1776 Fax: 281-265-1805 | |
Transformation Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2210 Granite Park Lane, Richmond, TX 77469 Phone: 469-912-1604 | |
Healing Path Clinic Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1727 Lake Charlotte Ln, Richmond, TX 77406 Phone: 832-584-4092 Fax: 832-584-4092 | |
Amboni Healthsource Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 25630 Farrier Dr, Richmond, TX 77406 Phone: 214-830-9906 | |
Utmb Health Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4 Jester Rd, Richmond, TX 77406 Phone: 281-277-3700 |